Navigation Links
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
Date:11/18/2011

tly and time-consuming monthly office visits for patients and their caregivers."

"This approval is an important step forward for Regeneron and for patients suffering with wet AMD, the most common cause of blindness in the U.S. in older adults," said Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron.  "We thank the patients and clinical investigators who participated in our clinical studies, the FDA, and the Regeneron employees who helped make this day possible.  Now that EYLEA is approved, we plan to make EYLEA available to patients within the next few days." 

About EYLEA™ (aflibercept) Injection Vascular Endothelial Growth Factor (VEGF) is a naturally occurring protein in the body.  Its normal role in a healthy organism is to trigger formation of new blood vessels (angiogenesis) supporting the growth of the body's tissues and organs.  However, in certain diseases, such as wet age-related macular degeneration, it is also associated with the growth of abnormal new blood vessels in the eye, which exhibit abnormal increased permeability that leads to edema. Scarring and loss of fine-resolution central vision often results.  

EYLEA, known in the scientific literature as VEGF Trap-Eye, is a recombinant fusion protein, consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1 and formulated as an iso-osmotic solution for intravitreal administration.  EYLEA acts as a soluble decoy receptor that binds VEGF-A and placental growth factor (PlGF) and thereby can inhibit the binding and activation of these cognate VEGF receptors.

EYLEA is indicated for the treatment of patients with neovascular age-related macular degeneration (wet AMD).  EYLEA is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipien
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
2. Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016
3. Regeneron Ranked by Science Magazine as the #2 Employer in the Global Biopharmaceutical Industry
4. Regeneron Announces Clinical Presentations at ASRS 2011 Annual Meeting
5. Regeneron Reports Second Quarter 2011 Financial and Operating Results
6. Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
7. Trading in Regeneron Common Stock Halted
8. Regeneron Reports First Quarter 2011 Financial and Operating Results
9. Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference
10. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
11. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), today ... ended March 31, 2015. "The first quarter ... driven by HETLIOZ and Fanapt.  As we are just ... in the U.S., the growth potential for HETLIOZ remains ... the growth potential of this product through the coming ...
(Date:5/6/2015)... -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) ... March 31, 2015. Total revenues for the ... million from $136.8 million in the first quarter of ... included $127.8 million in royalty and license payments from ... million in net royalty payments from acquired royalty rights ...
(Date:5/6/2015)... Delcath Systems, Inc. (NASDAQ: DCTH ), ... oncology with an emphasis on the treatment of primary ... three months ended March 31, 2015.  ... , Achieved quarterly product revenue of $0.44 million, ... first quarter of 2014; , Activated a prospective ...
Breaking Medicine Technology:Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 9Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 10Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 11Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 12PDL BioPharma Announces First Quarter 2015 Financial Results 2PDL BioPharma Announces First Quarter 2015 Financial Results 3PDL BioPharma Announces First Quarter 2015 Financial Results 4PDL BioPharma Announces First Quarter 2015 Financial Results 5PDL BioPharma Announces First Quarter 2015 Financial Results 6PDL BioPharma Announces First Quarter 2015 Financial Results 7Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8
... Fla., May 18, 2012   Sensus Healthcare ... Center of Dallas, TX are proud to announce ... Series for practitioners, healthcare professionals, and patients. SRT ... for the provider and patient populations.  The objectives ...
...  Not all discount dental plans are created equal, according ... Dental Health . Unexpected fees totaling hundreds of dollars are ... discount dental plan specialists, fee discounts are very limited and ... the states where they operate. Unknown lab ...
Cached Medicine Technology:Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients 2Consumers Are Advised to Be Aware of Hidden Costs in Some Discount Dental Plans 2
(Date:5/6/2015)... (PRWEB) May 06, 2015 Chesapeake ... the state of Virginia to acquire Intuitive Surgical, ... robot. The system upgrade includes enhanced surgical technique ... invasive procedures across a wide spectrum of specialties. ... reduced pain and quicker recovery times. , “As ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Prime ... supplier, is excited to announce a new series ... reduce the industry’s carbon footprint while improving treatment ... feature Eco-Flex™, the world’s first waste ... a game-changer for hydrotherapists,” claims the company’s president, ...
(Date:5/6/2015)... 2015 The Beryl Institute announces the ... Patient Experience Journal (PXJ), an international, open access, peer-reviewed ... and improving patient experience. The second volume of PXJ ... globally, helps align the voices engaged and provides the ... in association with The Beryl Institute, Volume 2, Issue ...
(Date:5/6/2015)... Ohio (PRWEB) May 06, 2015 Animals make ... shows they are also good for your health. An Ohio ... today reports an increase he's seeing with health advantages of ... things happen. When it comes to pet ownership, there are ... improvements,” Dr. Scott Leffler of the Animal ...
(Date:5/6/2015)... Denver, Colorado (PRWEB) May 06, 2015 ... own success? , Next month the Centennial State will ... legal, recreational cannabis sales to adults. And while Colorado’s ... rapid growth during that time, it’s also facing some ... the state are currently facing shortages, especially in the ...
Breaking Medicine News(10 mins):Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3
... leaders in stem cell research from the Cedars-Sinai Regenerative ... largest interdisciplinary stem cell meeting Oct. 3-5 in ... by the Cedars-Sinai Regenerative Medicine Institute, is the flagship ... community. The Summit will feature more than 170 ...
... Clinic has received a $750,000 grant from the Cleveland ... Cardiology. Stanley Hazen, M.D., Ph.D., will ... research spans a broad range of topics, from researching ... to identifying non-invasive testing for asthma. Recently, he published ...
... Sept. 29 (HealthDay News) -- Working rotating shifts is ... according to new Canadian research that suggests modern shift ... as older, more extreme shift schedules. "Recent research ... cancer, although the biological mechanism responsible for this observation ...
... tissue may play a different role in colon and breast ... the University of Illinois at Chicago College of Medicine. ... gut cells -- and in cancerous, but not normal, breast ... function of this protein in the gut, where it regulates ...
... Peter J. Stang, Ph.D., editor of the Journal of ... members Jacqueline K. Barton, Ph.D. and Rakesh Agrawal, Ph.D., ... Obama to receive the nation,s highest honors in science and ... inventors is guided by a passion for innovation, fearlessness even ...
... (NSF) has awarded $6 million to fund three projects ... four-year, $2 million grant was awarded through the NSF,s ... "The EFRI research teams will probe some ... said Sohi Rastegar, director of EFRI. "If they are ...
Cached Medicine News:Health News:Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit 2Health News:Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit 3Health News:Modern Shift Work Patterns May Be Less Harmful to Health 2Health News:Knockout of protein prevents colon tumor formation in mice 2Health News:White House honors editor of American Chemical Society journal and 2 ACS members 2Health News:Georgia Tech researchers receive 3 NSF Emerging Frontiers awards 2Health News:Georgia Tech researchers receive 3 NSF Emerging Frontiers awards 3Health News:Georgia Tech researchers receive 3 NSF Emerging Frontiers awards 4
All Day Comfort for the Lower Body...
All Day Comfort for the Upper Body...
The Skirts and Vests are made with .50mm Pb in the front and .25mm Pb in the back. When worn, the overlap areas in the front of both the skirt and vest provide 1.0mm Pb protection. The velcro fastene...
The Velcro Apron provides .50mm Pb protection with the added ease of velcro closures. This form-fitting apron offers comfort and protection while at the same time allowing for easy-on/easy-off access...
Medicine Products: